logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

DexCom, Inc.

DXCM

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time APIā€¦ read more

Healthcare

Medical Devices

20 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$80.95

Price

+1.24%

$0.99

$79.96

Previous Close

$80.29

Open

Premium

52w Discount
Market Cap

$31.745b

Large

Price/Earnings

57x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

+26.7%

EBITDA Margin

+15.5%

Net Profit Margin

+18.1%

Free Cash Flow Margin
Revenue

$4.301b

+6.6%

1y CAGR

+14.2%

3y CAGR

+15.3%

5y CAGR
Earnings

$571.500m

-0.8%

1y CAGR

+21.4%

3y CAGR

+30.4%

5y CAGR
EPS

$1.44

+1.4%

1y CAGR

+24.4%

3y CAGR

+32.5%

5y CAGR
Book Value

$2.573b

$7.327b

Assets

$4.754b

Liabilities

$2.579b

Debt
Debt to Assets

35.2%

2.5x

Debt to EBITDA
Free Cash Flow

$570.800m

-9.5%

1y CAGR

+27.2%

3y CAGR

+138.4%

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
ā†‘ TopSummaryPriceFinancialsPress Releases
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.